DGX

Quest Diagnostics Incorporated
$207.44
-0.61 (-0.29%)
Mkt Cap 22.96B
Volume 430,817
52W Range 164.65-219.2
Sector Healthcare
Beta 0.57
EPS (TTM) 9.17
P/E Ratio 22.62
Revenue (TTM) 11.28B
Rev Growth (5Y) +3.2%
EPS Growth (5Y) -3.6%
AlphaVal · Fair Value
What we estimate one share is worth
$169.98
Overvalued moderate signal
22.0% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
C+
Stable Earnings Power
59.2 / 100 composite
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 11.04B 9.87B 9.25B 9.88B 10.79B 9.44B 7.73B 7.53B 7.71B 7.51B 7.49B 7.43B
Net Income 992.00M 871.00M 854.00M 946.00M 2.00B 1.43B 858.00M 736.00M 772.00M 645.00M 709.00M 556.00M
EPS 8.87 7.80 7.59 8.12 15.90 10.68 6.38 5.41 5.63 4.58 4.92 3.83
Free Cash Flow 1.36B 909.00M 864.00M 1.31B 1.83B 1.59B 843.00M 817.00M 923.00M 776.00M 547.00M 630.00M
FCF / Share 12.24 8.19 7.71 11.33 14.64 11.84 6.29 6.01 6.74 5.54 3.80 4.34
Operating CF 1.89B 1.33B 1.27B 1.72B 2.23B 2.00B 1.24B 1.20B 1.18B 1.07B 810.00M 938.00M
Total Assets 16.23B 16.15B 14.02B 12.84B 13.61B 14.03B 12.84B 11.00B 10.50B 10.10B 9.96B 9.88B
Total Debt 6.92B 7.09B 5.50B 4.71B 4.77B 4.81B 5.42B 3.99B 3.85B 3.73B 3.65B 3.76B
Cash & Equiv 420.00M 549.00M 686.00M 315.00M 872.00M 1.16B 1.19B 135.00M 137.00M 359.00M 133.00M 192.00M
Book Value 7.17B 6.78B 6.31B 5.89B 6.44B 6.76B 5.64B 5.22B 4.92B 4.63B 4.68B 4.30B
Return on Equity 0.14 0.13 0.14 0.16 0.31 0.21 0.15 0.14 0.16 0.14 0.15 0.13
DGX News
Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term
Jul 10, 2026 06:41 AM · zacks.com
Quest Diagnostics Now the Largest Clinical Reference Lab to Extend Oncology Test Access Through OncoEMR MPI
Jul 08, 2026 04:52 AM · prnewswire.com
Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock
Jul 06, 2026 06:51 AM · zacks.com
Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run?
Jul 02, 2026 06:16 AM · zacks.com
DGX's Stock Rises on Haystack MRD Test's Approval From NYSDOH
Jun 25, 2026 07:31 AM · zacks.com
Quest Diagnostics Inc (DGX) Stock Up 3.0% but GF Value Says Overvalued -- GF Score: 83/100
Jun 24, 2026 02:12 PM · gurufocus.com
Quest Diagnostics Receives New York State Approval for Haystack MRD®, Broadening Patient Access to ctDNA Minimal Residual Disease Testing
Jun 24, 2026 04:52 AM · prnewswire.com
Is it Apt to Hold Quest Diagnostics Stock in Your Portfolio Now?
Jun 23, 2026 06:01 AM · zacks.com
Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock
Jun 19, 2026 06:51 AM · zacks.com
Quest Diagnostics (DGX) is a Top-Ranked Value Stock: Should You Buy?
Jun 18, 2026 06:41 AM · zacks.com